Quick Answer
Elevance Health, Inc. reported Cash And Cash Equivalents At Carrying Value of $9.49 billion for the year ending 2025.
- Elevance Health, Inc. showed an increase of +14.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Elevance Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Elevance Health, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 97.1%.
- Historical annual values: Fiscal year 2025: $9.49 billion | Fiscal year 2024: $8.29 billion | Fiscal year 2023: $6.53 billion | Fiscal year 2022: $7.39 billion | Fiscal year 2021: $4.88 billion | Fiscal year 2020: $5.74 billion | Fiscal year 2019: $4.94 billion | Fiscal year 2018: $3.93 billion | Fiscal year 2017: $3.61 billion | Fiscal year 2016: $4.08 billion | Fiscal year 2015: $2.11 billion | Fiscal year 2014: $2.15 billion | Fiscal year 2013: $1.58 billion | Fiscal year 2012: $2.48 billion | Fiscal year 2011: $2.20 billion | Fiscal year 2010: $1.79 billion | Fiscal year 2009: $4.82 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: